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Introduction Ventricular myocardial remodeling is a cause of heart failure
in ARVD patients. Angiotensin-converting enzyme (ACE) inhibitors inhibit
the TGF-B pathway and have an anti-apoptotic action. ACE inhibitors are cur-
rently prescribed to reduce hypertension, to treat heart failure or to protect the
heart following ischemic insult. Expression patterns of matrix metallopro-
teinase-9 (MMP-9) and its specific inhibitors, tissue inhibitor of metallopro-
teinases (TIMP) 1 and 2, are closely correlated with physiological and
pathological processes characterized by the degradation and accumulation of
the extracellular matrix. We aimed to study the turnover of tissue collagen in
patients.
Methods Dosages ofmmP9 and its inhibitors, TIMP1 and TIMP2, were
performed in 26 patients treated with beta blockers (BB) and ACEs and in 20
patients treated with BB without ACEs. Each patient had blood samples taken
one year apart. Tissue collagen turnover was identified by the evolution of
themmP9/TIMP1 ratio and themmP9/TIMP2 ratio between the 2 time samples
(Student’s t-test for paired samples).
Results A stabilization of themmP9/TIMP1 andmmP9/TIMP2 ratio was
present in patients treated with angiotensin-converting enzyme inhibitors
(3.04±1.88 vs 3.36±2.86 formmP9/TIMP1; 8.79±8.18 vs 8.31±6.70 formmP9/
TIMP2). In contrast, there was a significant increase of themmP9/TIMP1 ratio
in patients treated without ACE inhibitors (2.74±2.36 vs 4.53±3.62, p=0.03).
No significant increase ofmmP9/TIMP2 was observed (7.39±5.17 vs
9.00±6.64) in these patients. The increasedmmP9/TIMP1 ratio for BB patients
was triggered by an increase inmmP9 concentration (554.8±368.5 vs.
876.0±619.7, p=0.04) and a decrease in TIMP1 concentration (223.2±72.8 vs
205.1±71.6, p=0.01).
Conclusion This study suggests that ACE inhibitors decrease myocardial
damage in ARVD patients and strengthens the need for a prospective clinical
evaluation of antifibrotic drugs in this disease.
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Introduction Mutations in the DSC2 gene cause Arrhythmogenic Right
Ventricular Dysplasia (ARVD). The mechanisms by which these mutations
confer histologic substrate remain unknown. It has been suggested that endog-
enous caspase-1 activity promotes the magnitude of the inflammatory
response. 
Materials and Methods Fragments of cardiac tissue from 2 patients were
collected after macroscopic and histopathological examination the patients’
hearts. A 63-year-old patient with ARVD caused by a DSC2 mutation
(p.Arg132Cys) underwent heart transplantation. The diseased heart genome-
wide expression profiling was compared with that of a non-diseased donor
heart. The retained genes of interest were listed and classified according to
their biological functions using Ingenuity Pathways Analysis (Ingenuity Sys-
tems Inc., Mountain View, CA). RT-qPCR and Western Blot (WB) were used
to confirmed genes of interest.
Results Transcriptomic and RT-PCR data first revealed a down-expression
of DSC2 mRNA and an unexpected overexpression of DSC3 mRNA in the
posterior right ventricle of the ARVC patient (Figure) In the ARVD heart,
DSC3 was found to be cleaved. Prediction software revealed that this cleavage
could be due to Caspase-1. We observed an overexpression of Casp1 and
other elements of inflammasome (CARD16, NLRP3) in the posterior RV of
the ARVC patient. A down-expression of DSG2, DSP and RyR2 was also
documented. Biological pathways analysis identified a relationship of Casp1
with apoptosis (BCL2, FOS), fibrogenesis (Col3A1, Col4A1, Col4A2,mmP9)
and adipogenesis (IGF1, ADIPOQ) in the ARVC heart.
Conclusion These findings suggest that in ARVD patients with a DSC2
variant: 1) there is a switch DSC2/DSC3 2) endogenous caspase-1 activity, by
cleaving DSC3, contributes to desmosome dysfunction.
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Background Inflammation is deeply involved in the pathophysiology of
ischemia-reperfusion (I/R) lesions and remodeling phenomena after an acute
myocardial infarction (AMI), responsible for heart failure. Colchicine exerts
anti-inflammatory effects, through the inhibition of neutrophil chemoattrac-
tion, the inflammasome and proinflammatory cytokines. We aimed at eva-
luating the impact of colchicine on the infarct size in a mouse model.
Method Myocardial I/R injury were induced in 19, 8 to 10 weeks, male
C57BL/6 mice, after left thoracotomy, by ligating the left coronary artery for
45min followed by reperfusion. 400 μg/kg of Colchicine or placebo was
administrated via the intraperitoneal (i.p) route 25 minutes before the reperfu-
sion (blinded administration). 24 hours later, mice were sacrificed after intra-
cardiac Evans blue injection, the heart was removed and the left ventricle
(LV) was cut in transverse slices stained with Triphenyl-tetrazolium chloride
(TTC). The area at risk (AAR) and infarcted area (IA) were determined by















Abstract 0193 – Figure: RT-PCR of DSC3 in heart samples
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computerized planimetry, the AAR/total area and IA/AAR ratios were calcu-
lated. All data are expressed as percentage mean and standard error of mean.
Results 10 animals were included in the control group and 9 in the Colchi-
cine group (blinded adjudication). All the animals were successfully operated
and survived at 24 hours. The AAR/total area ratios were respectively
54.44±2.9% in the Colchicine group versus 51.96±4.4% in the control group,
p=n.s. No difference in infarct size could be found in Colchicine treated mice
in comparison to control mice with IA/AAR ratios respectively at 49±3.4%
versus 53.7±5.3%, p=n.s.
Conclusion In conclusion, reduction of infarct size could not be obtained
by treatment with Colchicine at the present concentration after induced myo-
cardial infarction in mice. Further analysis should be performed to evaluate
inflammatory cells accumulation in myocardium and inflammation pathways
as well as LV remodeling. 
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Background The study of the changing levels of microRNAs (miRNAs) in
different biological body environments as diagnostic and prognostic marker
for ST-elavation myocardial infarction (STEMI) calls attention of scientists.
We conducted a research to determine the level of several microRNAs in
blood plasma, isolated monocytes and platelets of STEMI pts in the dynamics
of disease development (the 1st and the 7th days). Into the study we included
the evaluation of some cardiac microRNAs (1, 208a, 208b, 499), inflamma-
tion-related and hypoxic-response microRNA-155 and –210.
Methods 20 STEMI pts (mean age 54,85±2,2 years) were identified in
National Scientific Center Institute of Cardiology M.D. Strazhesko. The
control group included 10 subjects of comparable sex and age without any evi-
dence of coronary artery disease. Expression miRNAs was quantified from
plasma, isolated monocytes and platelets using quantitative Real-Time poly-
merase-chain reaction system.
Results In plasma the microRNA-1 level was significantly higher only on day
7, the microRNA-155 level was lower on the first day and 15 times higher on day
7. In platelets the microRNA-1 level was 4.2 times higher on the first day of
STEMI in comparison with the control group and on day 7 of STEMI returned
to the level of the control group. The changes in monocytes were more revealing:
the microRNA-1 level was higher by 28 times on the first day of STEMI, the
microRNA-208a level was higher by 2 times on day 1 and by 19 times on day 7
of STEMI, and the microRNA-155 level was higher by 17 times on day 1 and by
260 times on day 7 of STEMI in comparison to the control group. 
Conclusions The miRNA distribution is unique amongst blood plasma,
isolated monocytes and platelets in pts with STEMI. Our results show higher
informational content of evaluation of certain miRNAs in isolated cells com-
paring with blood plasma, and expresses the necessity of determining miRNA
levels in the dynamics of STEMI.
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Background Coronary artery disease is influenced by both environmental
and genetic factors. Current evidence shows that the CD40-CD40 ligand
(CD40-CD40L) system plays a crucial role in the development, progression
and outcome of acute coronary syndrome. A single nucleotide polymorphism
(SNP) located at position –1 in the Kozak sequence of the CD40 gene
(rs1883832; C>T) has been associated with the development of acute coronary
syndrome. The purpose of the study was to explore the association between
the C/T (–1) single nucleotide polymorphism in the CD40 gene and myocar-
dial infarction (MI) in the Tunisian male population.
Methods A total of 273 unrelated Tunisian patients with MI and 219
healthy controls were genotyped using the polymerase chain reaction-restric-
tion fragment length polymorphism (PCR-RFLP) method. Clinical parameters
such as fasting serum total cholesterol, high-density lipoprotein cholesterol
(HDL-C), triglycerides, and plasma glucose were detected by autoanalyzer
assay. Weight, height and blood pressure (BP) were measured and body mass
index (BMI) was calculated. 
Results Patients with MI had significantly higher frequency of the TT gen-
otypes compared to controls (12.5% vs. 5.9%; OR=1.43, 95% CI: 1.08 – 1.
89, p=0.011). The MI patient group showed a significant higher frequency of
the T allele compared to the controls (0.33 vs. 0.26; OR=1.45, 95% CI: 1.09
– 1.94, p=0.008). The association between the C/T (–1) single nucleotide
polymorphism in the CD40 gene and MI remained significant after adjustment
for other well-established cardiovascular risk factors.
Conclusion Our study suggests that C/T (–1) single nucleotide polymor-
phism in the CD40 gene might contribute to the susceptibility to MI in the
Tunisian male population. Further replication with larger numbers, and popu-
lations of different ethnicities, are needed to confirm our finding. 
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Introduction Myocardial infarction (MI) is a major cause of morbidity and
mortality and is a main etiology of heart failure. The process of MI is modu-
lated by the inflammatory response. Many studies have shown a significant
inflammatory response phenomenon in pathogenesis of MI.
Objectives The aim of this study is to discuss the role of pro-inflammatory
(IL8,TNFα) and anti-inflammatory (IL10) cytokines that are among others
decried involved in the process of remodeling post-myocardial infarction.
Methods Prospective, monocentric case-control study that included
82 patients diagnosed with a first episode of myocardial infarction and low
LVEF and 30 healthy subjects.The quantification of IL10 was based on the
technique of sandwich ELISA. The CLIA technique was used for quantifica-
tion of IL8 and TNFα.All patients were evaluated by an echocardiography
after revascularisation and one month after to study cardiac remodeling.
Abstract 0140 – Figure: Impact of Colchicine on infarct size in mouse
